Leading UK Pharmacies trust Deltera
The Chikungunya vaccine PGD enables pharmacists to offer protection against this mosquito-borne viral threat, particularly for travellers to endemic regions. With the IXCHIQ vaccine now available, Deltera provides the digital framework to manage eligibility and administration safely and efficiently.
A Fully Digital Clinical Platform
Integrated Bookings and Payments
Secure & Connected Patient Records
Ditch the paperwork with secure digital records. Deltera automatically shares treatment summaries with the patient’s and sends the required notification to their GP instantly.
Training and Eligibility Requirements
To ensure clinical safety and regulatory compliance, all practitioners using this PGD must meet the following professional standards:
- Professional Registration: Must be a registered healthcare professional (e.g., Pharmacist) with a valid GPhC or PSNI registration and personal professional indemnity insurance.
- Clinical Competency: Practitioners must be self-certified as competent in the specific clinical area covered by this PGD and stay up to date with relevant national guidelines (e.g., The Green Book or NICE clinical summaries).
- Mandatory Training: Current certification in Basic Life Support (BLS) and the management of anaphylaxis is required for all injectable services.
- PGD Authorisation: The practitioner must have read and signed the PGD document within the Deltera Clinical Dashboard, with the authorisation counter-signed by the designated organisational lead or Superintendent.
- Premises Standards: Services must be conducted in a private consultation room that meets national standards for patient confidentiality and clinical safety.
Speak to the clinicians behind the platform
We understand the complexities of PGDs and clinical governance in the UK. Schedule a meeting with our team to see how we can help you navigate the changing landscape of community pharmacy.
Access related PGDs
FAQs
Travellers aged 18 and older visiting regions with a known risk of Chikungunya virus are typical candidates. Deltera’s pre-screening tool helps pharmacists identify those most at risk based on their specific itinerary.
The current Chikungunya vaccine (IXCHIQ) is administered as a single dose. Deltera’s portal keeps a permanent record of the administration date for future travel consultations.
As a live vaccine, specific criteria regarding immunosuppression and pregnancy must be met. Our digital clinical logic flags these "Red Flags" during the pre-screen to ensure safety.
If a patient falls outside the standard PGD criteria but the vaccine is still clinically indicated, our IP Bridge allows for a seamless handover to an Independent Prescriber.
Still have questions?
Our team are here to support you.
Discover Deltera Practice Management
Deltera Practice Management digitalises your private pharmacy services, providing the complete pharmacy software package to offer a full range of Patient Group Directions (PGDs). Gain the oversight and efficiency you need to thrive.
